跳至主要内容
临床试验/NL-OMON37110
NL-OMON37110已完成2 期

Prospective multi-centre study of low-dose Iodine125 (I-125) prostate brachytherapy performed after transurethral resection. PROBATE study - I125 postTURP

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Histologically proven prostate cancer (adenocarcinoma) of low or intermediate risk following the D*Amico classification.
  • -Prostate volume < 50 cc
  • -History of TransUrethral Resection of the prostate (TURp), performed at least 3 months before the brachytherapy procedure.
  • -Rim of prostate tissue of at least 1 cm around the post-TURp urethral defect at thepostero-lateral sides of the prostate
  • -Absence of significant TURP-induced urinary incontinence
  • - IPSS <15

排除标准

  • -Locally advanced (stage T3 or T4 , or metastatic (stage N+ or M+) prostate cancer
  • -High grade tumours defined by Gleason score 8 or above
  • -Co-morbidity which would exclude the patient from a transperineal implant procedure.

研究者

相似试验